![[Search]](/static/images/search.gif){kind=small}
![[A-Z Index]](/static/images/az.gif){kind=small}
![[Contact]](/static/images/contact.gif){kind=small}
![[University of Cambridge]](/static/images/identifier2.gif){kind=small}
![[Talks.cam]](/static/images/talkslogosmall.gif)
Dr Yuya Mizuno, King's College London
Thursday 20 November 2025, 12:30-13:30
Immune alterations in first-episode psychosis and the effects of natalizumab: A neuroimaging study with concurrent CSF measures
- đ¤ Speaker: Dr Yuya Mizuno, King's College London
- đ Date & Time: Thursday 20 November 2025, 12:30 - 13:30
- đ Venue: Hybrid (in-person at the Herchel Smith Building and online via zoom)
Questions? Contact
Oliver Knight
Abstract
It is hypothesised that microglia, the primary immune cells in the brain, play a key role in the pathophysiology of schizophrenia. To address this, we investigated the effects of 3-month treatment with the monoclonal antibody natalizumab on a PET biomarker of microglia, CSF cytokines, and symptom measures in people with first-episode psychosis. I will be presenting unpublished findings from this study and future directions.
Series This talk is part of the Department of Psychiatry & CPFT Thursday Lunchtime Seminar Series series.
Included in Lists
- Cardiovascular Epidemiology Unit Special Seminars
- Department of Psychiatry & CPFT Thursday Lunchtime Seminar
- Department of Psychiatry & CPFT Thursday Lunchtime Seminar Series
- Department of Psychiatry talks stream
- Department of Public Health and Primary Care
- Hybrid (in-person at the Herchel Smith Building and online via zoom)
- my List
- PhD related
- Psychology talks and events
- PublicHealth@Cambridge
- Yishu's list
Note: Ex-directory lists are not shown.